John Parnell Appointed to President and COO of Parnell Pharmaceuticals, Inc.

Share Article

Parnell Pharmaceuticals, Inc. (http://parnellpharm.com), a lead developer of products dedicated to restoring and maintaining mucosal integrity, has appointed John F. Parnell to President and Chief Operating Officer, and to the Board of Directors.

Past News Releases

RSS

Parnell Pharmaceuticals, Inc. (http://parnellpharm.com), a lead developer of products dedicated to restoring and maintaining mucosal integrity, has appointed John F. Parnell to President and Chief Operating Officer, and to the Board of Directors.

Since joining the company in 1985, Parnell, age 42, has served in various roles, including senior marketing positions, and most recently as director of operations, and vice-president. He succeeds Parnell Pharmaceuticals founder Dr. Francis Parnell who will continue as chairman and chief executive officer. John Parnell is a graduate of Boston University where he received a B.A. degree in International Relations.

Parnell Pharmaceuticals, founded in 1981, develops and markets natural refined products which are physician formulated and patient tested to improve the quality of life and to provide successful aging. The patented products are derived from the naturally occurring Yerba Santa plant, and include Mouth Kote(R) dry mouth spray, Pretz(R) nasal and sinus products and Feminease(R) vaginal moisturizer.

Yerba Santa is a plant indigenous to the foothills of the Pacific Northwest, and has been used as an herbal remedy by many Native American tribes for centuries.

For further information, contact Dr. Francis Parnell, Chairman and CEO
Tel: 415-256-1800
Fax: 415-256-8099

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Dr. Francis Parnell
Visit website